Analyst Price Target is C$11.74
▲ +145.09% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Quipt Home Medical in the last 3 months. The average price target is C$11.74, with a high forecast of C$11.74 and a low forecast of C$11.74. The average price target represents a 145.09% upside from the last price of C$4.79.
Current Consensus is
Strong Buy
The current consensus among 1 contributing investment analysts is to buy (strong buy) stock in Quipt Home Medical. This Strong Buy consensus rating has held steady for over two years.
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Read More